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Group II nucleopolyhedroviruses (NPVs), e.g., Spodoptera exigua MNPV, lack a GP64-like protein that is
present in group I NPVs but have an unrelated envelope fusion protein named F. In contrast to GP64, the F
protein has to be activated by a posttranslational cleavage mechanism to become fusogenic. In several
vertebrate viral fusion proteins, the cleavage activation generates a new N terminus which forms the so-called
fusion peptide. This fusion peptide inserts in the cellular membrane, thereby facilitating apposition of the viral
and cellular membrane upon sequential conformational changes of the fusion protein. A similar peptide has
been identified in NPV F proteins at the N terminus of the large membrane-anchored subunit F1. The role of
individual amino acids in this putative fusion peptide on viral infectivity and propagation was studied by
mutagenesis. Mutant F proteins with single amino acid changes as well as an F protein with a deleted putative
fusion peptide were introduced in gp64-null Autographa californica MNPV budded viruses (BVs). None of the
mutations analyzed had an major effect on the processing and incorporation of F proteins in the envelope of
BVs. Only two mutants, one with a substitution for a hydrophobic residue (F152R) and one with a deleted
putative fusion peptide, were completely unable to rescue the gp64-null mutant. Several nonconservative
substitutions for other hydrophobic residues and the conserved lysine residue had only an effect on viral
infectivity. In contrast to what was expected from vertebrate virus fusion peptides, alanine substitutions for
glycines did not show any effect.
The members of the Baculoviridae family are large, envel-
oped, double-stranded DNA viruses that are exclusively patho-
genic for arthropods, predominantly insects of the order Lep-
idoptera (1). Baculoviruses are classified into two genera,
Nucleopolyhedrovirus (NPV) and Granulovirus (GV). The
NPVs can be phylogenetically subdivided into group I and II
NPVs (6, 10, 12, 13). The budded virus (BV) phenotype of
group I NPVs contains a GP64-like major envelope glycopro-
tein. This protein is involved in viral attachment to host cells
(11), triggers low-pH-dependent membrane fusion during BV
entry by endocytosis (4, 20, 35, 42), and is required for efficient
budding from the cell surface (27, 29).
In contrast, BVs of group II NPVs and GVs lack a homolog
of GP64. The low-pH-dependent membrane fusion during BV
entry by endocytosis is triggered in this case by a so-called F
protein (17, 32). F homologs are also found as envelope pro-
teins of the insect errantiviruses while cellular homologs are
found in the fruit fly Drosophila melanogaster and in the Afri-
can malaria mosquito Anopheles gambiae (25, 36). Unlike
GP64, the F proteins are structurally similar to fusion proteins
from several vertebrate viruses such as orthomyxoviruses and
paramyxoviruses. Recently, it has been shown that the GP64
protein in BVs of Autographa californica MNPV (AcMNPV)
can be replaced by the F protein of group II NPVs (24),
implying that F is functionally analogous to GP64.
Like several mammalian viral envelope fusion proteins, the
baculovirus F protein has to be posttranslationally cleaved by a
proprotein convertase (furin) to become fusogenic (43). Also,
for some errantiviruses it has been shown that the envelope
protein is posttranslationally cleaved (31, 38, 39). Cleavage
seems to be a general mechanism for viruses to activate their
fusion proteins (21). In a number of virus families this cleavage
occurs in front of a strongly hydrophobic sequence, the so-
called fusion peptide (44, 45). These fusion peptides are be-
lieved to translocate upon cleavage to the top of the protein
and to insert into the target membrane after exposure to low
pH or receptor binding. This translocation facilitates the ap-
position of viral and cellular membranes upon further confor-
mational changes of the fusion protein (21). Comparison of
available F protein sequences reveals a conserved strongly
hydrophobic domain with the consensus sequenceGXB
GXKGXDXXDXXX, where represents hydropho-
bic amino acids, B stands for an aspartic acid or an asparagine
residue, and X represents any amino acid (Fig. 1). This domain
is preceded by a furin-like cleavage site in the F proteins from
group II NPVs, GVs, and errantiviruses, whereas this domain
is more or less absent in the remnant F protein from group I
NPVs and in the cellular homologs (36). This strongly hydro-
phobic sequence at the N terminus of the membrane-anchored
Spodoptera exigua MNPV (SeMNPV) F1 fragment has all the
characteristics of a fusion peptide (45). It is well conserved
within the virus family (Fig. 1), when modeled in -helix, it
displays one face with a hydrophobic index (H.I.) of about 0.9,
according to the normalized consensus scale of Eisenberg (8),
and a back face with hydrogen bonding potential, and it con-
tains glycines on one side of the helix (Fig. 2A).
The role in the fusion process of the three conserved
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charged amino acids in the putative fusion peptide, immedi-
ately downstream of the proprotein convertase cleavage site, of
the Lymantria dispar MNPV (LdMNPV) F protein has already
been studied by site-directed mutagenesis (33). In this study,
site-directed mutagenesis was used to investigate the role in
viral propagation and infectivity of the conserved glycines and
lysine as well as the hydrophobic amino acids in the putative
fusion peptide of the SeMNPV F protein. Several conservative
and nonconservative substitutions were introduced in the fu-
sion domain, and their impact on virus propagation and infec-
tivity was examined by using a recently developed AcMNPV
pseudotyping system in which the envelope fusion protein
GP64 can be replaced by the heterologous envelope fusion
protein F of SeMNPV (24). The virus propagation of mutant
infectious viruses as well as the amount of BV produced gives
further credence for the role of the conserved domain of the
baculovirus F protein as the fusion peptide.
MATERIALS AND METHODS
Cells. Spodoptera friguperda cell lines IPLB-Sf21 (41) and Sf9Op1D (35) (pro-
vided by G. W. Blissard, Ithaca, N.Y.) were cultured at 27°C in plastic culture
flasks (Nunc) in Grace’s insect medium, pH 5.9 to 6.1 (Gibco-BRL), supple-
mented with 10% fetal bovine serum.
Donor plasmids containing envelope protein genes. A silent mutation was
introduced into the coding sequence of the SeMNPV F open reading frame to
generate an NdeI cloning site. Therefore, nucleotide 525 in the f open reading
frame was changed from C to T by PCR-based site-directed mutation, according
to the method of Sharrocks and Shaw (37). The 5 mutagenic primer 5-CGAC
GCTCACGAACTGCATATGCTCGCCAACACCACAA-3 (underlined and
boldface sequences represent an NdeI site and the mutation, respectively) and
the 3 primer 5-GAGAGGCACGGGCCACGAAAGG-3 (primer downstream
of the PmeI site) were used in conjunction with plasmid pFBgusSe8 (24) as a
FIG. 1. Amino acid sequence alignment of the SeMPNV F protein domains near the protease cleavage site with the corresponding domain of
the F proteins of group I NPVs (A), dipterans (B), lepidopteran NPVs (C), group II NPVs (D), GVs (E), and errantiviruses (F). Virus and dipteran
abbreviations and GenBank accession numbers of the F proteins are shown on the left and right, respectively. The conserved amino acids are
boxed. The consensus sequence is shown below the alignment, in which B represents D or N,  indicates a hydrophobic amino acid (H.I., 0.12),
and X represents any amino acid. A schematic presentation of the SeMNPV F protein, with the consensus sequence shown in gray boxes, is shown
at the bottom. N, N terminus; C, C terminus; SP, signal peptide; TM, transmembrane domain; S-S, disulfide bridge.
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template with Pfu polymerase (Promega). The PCR product (346 bp) was aga-
rose gel purified, and the single strand containing the mutation at the 3 end
served as a 3 mutagenic primer in a second PCR with 5 primer 5-TTATGG
ATCCATGCTGCGTTTTAAAGTGAT-3 (the underlined sequence represents
a BamHI site) with high-fidelity Expand long-template polymerase (Roche). The
second PCR product (862 bp) was cloned into pGEM-T (Promega) to generate
the intermediate plasmid pGEM-SeFNdeI. Plasmid pFBgusSeFNdeI was ob-
tained by swapping the BamHI/PmeI fragment of pGEM-SeFNdeI with the same
fragment of pFBgusSe8.
Mutations and deletions in the coding sequence of SeF, encompassing amino
acids 151 to 170 were performed as follows. For every mutant, a 5 phosphory-
lated primer pair (Table 1) was used with pGEM-SeFNdeI as a template and Pfu
polymerase (Promega) to amplify the entire vector. Finally, the 5 ends of the
PCR products were ligated to its own 3 ends, generating a new restriction
endonuclease site at the junction (Table 1). Clones containing the additional
restriction site were sequenced to confirm the mutation. The obtained mutations
in pGEM-SeFNdeI were introduced into pFBgusSeFNdeI by swapping the
BamHI/NdeI fragments.
Transfection infection assay. The gus reporter gene controlled by the p6.9
promoter and the mutant SeMNPV f genes under control of the gp64 promoter
from pFBgusSeFNdeI were transposed into the att Tn7 transposon integrase site
of a gp64-null AcMNPV bacmid (provided by G. W. Blissard) (24) according to
the Bac-to-Bac manual (Invitrogen). Transpositions of inserts from donor plas-
mids were confirmed by PCR with a primer corresponding to the gentamicin
resistance gene of the donor plasmid (P-gen-RV [5-AGCCACCTACTCCCAA
CATC-3]) in combination with a primer corresponding to the bacmid sequence
adjacent to the transposition site (M13/pUC forward primer [5-CCCAGTCAC
GACGTTGTAAAACG-3]). Bacmid DNA, positive in the PCR, was electro-
porated into DH10 cells to eliminate the helper plasmid and some residual
untransposed bacmid DNA.
Approximately 1 g of DNA of each recombinant bacmid was transfected into
1.5  106 Sf21 or Sf9Op1D cells with 10 l of Cellfectin (Invitrogen). At 5 days
posttransfection, transfected cells were stained for GUS activity according to the
Bac-to-Bac protocol (Invitrogen) to monitor transfection efficiency. The super-
natant was clarified for 10 min at 2,200  g and subsequently filter sterilized
(0.45-m pore size). One-fourth (500 l) of the supernatant was used to infect
2.0  106 Sf9 or Sf9Op1D cells, respectively. At 72 h postinfection, cells were split
into two portions. Cells of one portion were stained for GUS activity; the other
portion was used at 10 days postinfection to monitor viral propagation. The
gp64-positive bacmid served as a positive control for transfection and infection
while the gp64-null bacmid was used as a negative control for transfection and
infection (24). The SeFR149K bacmid was used as a negative control for F protein
cleavage (24).
BV amplification and preparation. Viruses carrying f genes that rescued the
gp64-null phenotype were amplified by infecting 1.0  107 Sf21 cells with 500 l
of cell supernatant from 10 days postinfection. Viruses carrying f genes that did
not rescue the gp64 deletion in Sf21 cells were amplified in a similar manner by
using Sf9Op1D cells. Cells were split every 3 to 5 days until all cells were infected.
Amplified pseudotyped viruses were titrated on Sf9Op1D cells by a 50% tissue
culture infective dose (TCID50) assay (30) and scored for infection by examining
cells for GUS expression.
The genotypes of the pseudotyped viruses were confirmed by PCR on purified
BV DNA by using primers P-SeF-mutant-FW (5-GGCGTTGACGGTCGAGG
CTAAAT-3) and P-SeF-mutant-RV (5-GTGCATCGCTTTTTCGGTGAGA
GG-3) to amplify a DNA fragment containing the incorporated restriction site
(Table 1). The amplified DNA fragment was subsequently subjected to restric-
tion enzyme analysis.
One-step growth experiments. To monitor infectious BV production from
viruses carrying mutant f genes that rescued the gp64-null phenotype, viral
growth results were generated by collecting infected cell supernatants. Sf21 cells
(1.5  105 cells per well, 24-well plates) were infected at a multiplicity of
infection (MOI) of 5.0 or 0.5 TCID50 U/cell for 1 h at 27°C. After infection, the
inoculum was removed and 0.5 ml of fresh medium was added to the cells. At 0,
24, 48, 72, 69, and 144 h postinfection, the infected cell supernatants were
FIG. 2. (A) Helical wheel presentation of the first 21 N-terminal
amino acids of the SeMNPV F1 fragment. The helix is typically am-
phipathic, with relatively polar amino acids (H.I., 0.48) above the
dotted line, with an average H.I. of 	0.24, and except for one aspartic
acid residue (D), nonpolar amino acids (H.I., 
0.62) below the dotted
line, with an average H.I. of 0.87. (B) Linear presentation of the first
21 N-terminal amino acids of the SeMNPV F1 fragment preceded by
the consensus furin recognition sequence (box). The open arrow indi-
cates the cleavage site. Underlined amino acids are conserved as
shown in Fig. 1. Solid arrows indicate the point mutations as well as the
substitutions described in this study.
TABLE 1. Primer pairs generating the desired mutation and a restriction endonuclease sitea
Mutant 5 primer (5–3) 3 primer (5–3) RE
b
site
SeF151–170 GCCCACGAACTGCATATGCTCGCC GCCGCGTTTAGAGCGTCTTTTCG NarI
SeFL151R CCGCTTTAATTTTATGGGACACGTCG CCGCGTTTAGAGCGTCTTTTC NotI
SeFF152R CCTTCGTAATTTTATGGGACACGTCG CCTCGTTTAGAGCGTCTTTTCGTC StuI
SeFM155R GCGGACACGTCGACAAATATCTG GGAAATTAAAAAGGCCGCGTTTAG SacII
SeFG156A CGTGGACAAATATCTGTTTGGCATTATG TGTGCCATAAAATTAAAAAGGCCGCGTTT Eco72I
SeFV158R CGACAAATATCTGTTTGGCATTATG CGATGTCCCATAAAATTAAAAAGGCCGCGTTT NruI
SeFK160L TCTATATCTGTTTGGCATTATGGACAG TCTACGTGTCCCATAAAATTAAAAAGG BglII
SeFF163K CTTGCGTGGCATTATGGACAGCGAC TACTTGTCGACGTGTCCCATAAAA ScaI
SeFG164A CGATTATGGACAGCGACGACGCTCAC CGAACAGATATTTGTCGACGTG NruI
SeFM166R CGCGACAGCGACGACGCTCACGA AATGCCAAACAGATATTTGTCGAC NruI
a Underlined sequences of primer pairs generate restriction sites after blunt-ended self-ligation of PCR products. Mutations are indicated in boldface type.
b RE, restriction endonuclease.
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collected. For each time point postinfection and each virus sample, duplicate
samples were generated. The quantity of infectious BVs in the samples was
determined by TCID50 assays on Sf9Op1D cells. A third sample was generated for
those duplicated samples for which titers differed by a factor of 2.5 or more.
Western blot analysis. BVs were amplified by infecting 1.0  107 Sf21 or
Sf9Op1D cells at an MOI of 0.5 TCID50 U/cell. Cells were split every 3 to 5 days
until all cells were infected. BVs were purified from the supernatants as de-
scribed previously (43). Equal amounts of BVs, determined by the Bradford
method (5), were disrupted in Laemmli buffer (125 mM Tris-HCl, 2% sodium
dodecyl sulfate, 5% 2-mercaptoethanol, 10% glycerol, 0.001% bromophenol blue
[pH 6.8]) and denatured for 10 min at 95°C. Proteins were electrophoresed in
sodium dodecyl sulfate-polyacrylamide gels and transferred onto Immobilon-P
membranes (Millipore) by semidry electrophoresis transfer (3). Membranes
were blocked overnight at 4°C in phosphate-buffered saline (PBS) containing 2%
milk powder, followed by incubation for 1 h at room temperature with either
polyclonal antibodies anti-F1 and anti-F2 (43), monoclonal antibody AcV5 (14),
or polyclonal antibody anti-VP39 (40) (provided by A. L. Passarelli, Manhattan,
Kans.), all at a 1:1,000 dilution in PBS containing 0.2% milk powder. After
washing three times for 15 min in PBS containing 0.1% Tween-20, the mem-
branes were incubated for 1 h at room temperature with a horseradish peroxi-
dase-conjugated appropriate secondary antibody (Sigma, DAKO) in PBS con-
taining 0.2% milk powder. After washing three times for 15 min in PBS
containing 0.1% Tween-20, the signal was detected by enhanced chemilumines-
cence technology as described by the manufacturer (Amersham).
Computer-assisted analysis. Protein comparisons with entries in the updated
GenBank and EMBL were performed with the FASTA and BLAST programs (2,
34). Sequence alignments were performed with the program ClustalW (EMBL
European Bioinformatics Institute, http://www.ebi.ac.uk) and edited with the
Genedoc Software (28). The -helix predictions were performed with the Pro-
tean software of DNASTAR by using the method of Garnier et al. (9).
RESULTS
Pseudotyping gp64-null AcMNPV with f mutants. To exam-
ine the role of the N terminus of the SeMNPV F1 fragment in
viral propagation and infectivity, mutational analysis on this
domain was performed. The hydrophilic arginine was substi-
tuted for hydrophobic amino acids (Fig. 2 and Table 1). Five of
these hydrophobic amino acids (F152, M155, V158, F163, and
M166) are conserved and one (L151) is nonconserved among F
homologs of group II NPVs, GVs, and errantiviruses (Fig. 1).
Alanine was substituted for glycines (G156 and G164), and a
hydrophobic leucine was substituted for the conserved lysine
(K160). Each mutation was marked by the presence of a new
restriction site. Furthermore, an F mutant with a deletion in
the conserved region (amino acids 151 to 170) of the fusion
peptide was also constructed. It was then determined whether
the F protein mutants could rescue BV propagation of a gp64-
null AcMNPV bacmid relative to the native F protein (24)
when transfected into Sf21 cells. Mutant f genes under control
of the AcMNPV gp64 promoter and a gus reporter gene down-
stream of the baculovirus p6.9 promoter were inserted simul-
taneously by Tn7-based transposition (23) into the gp64-null
AcMNPV bacmid. Sf21 cells were transfected with the con-
structed bacmids together with various control bacmids: gp64-
null AcMNPV bacmids containing (i) no envelope fusion pro-
tein gene (F) (negative control), (ii) AcMNPV gp64 (positive
control), (iii) SeMNPV f, (iv) SeMNPV fNdeI (f gene with silent
mutation creating an NdeI cloning site), and (v) SeMNPV
fK149R (f gene mutant negative in F0 cleavage). At 5 days
posttransfection, cells were stained for GUS activity (Fig. 3A1
to O1). The presence of infectious BVs in the supernatant was
determined by passaging the supernatants to new Sf21 cells. At
3 days postinfection, infected cells were demonstrated by their
GUS activity (Fig. 3A2 to O2). The bacmids SeFL151R,
SeFM155R, SeFG156A, SeFF152R, SeFV158R, SeFK160L, SeFF163R,
SeFG164A, and SeFM166R were all able to produce infectious
viruses (Fig. 3E to M), as were SeFNdeI (Fig. 3C) and the
positive controls, AcGP64 and SeF (Fig. 3A and B). The bac-
mids SeFF152R and SeF151-170 (Fig. 3F and N) and both neg-
ative controls (F and SeFK149R) (Fig. 3D and O) were not
able to produce infectious viruses, as expected. However, when
those bacmids were transfected into Sf9Op1D cells, which con-
stitutively express the Orgyia pseudogata MNPV GP64 protein
to pseudotype AcMNPV (35), infectious BVs could be dem-
onstrated (Fig. 3P to S), indicating that the defect in BV
propagation was attributable to the expression of an inactive
fusion protein.
BVs carrying an envelope fusion protein gene that rescued
the gp64-null phenotype were amplified by infecting Sf21 cells;
those BVs that were not rescued were amplified by using
Sf9Op1D cells as described in Materials and Methods. The
amplified viruses were all subjected to PCR analysis to verify
the introduced mutations in their f genes (Fig. 4). For viruses
containing the mutant f genes, PCR fragments of similar sizes
were obtained, whereas the SeF151-170 mutant showed a much
smaller fragment (Fig. 4A). Along with the desired mutations,
an additional restriction site was introduced into the f genes to
mark the mutation (Table 1), allowing the analysis of the
resulting PCR fragments by restriction enzyme analysis (Fig.
4B). From the patterns, it could be concluded that the gp64-
null AcMNPV viruses contained the correct mutations.
Western analysis of f gene-pseudotyped gp64-null AcMNPV
viruses. The effect of the various mutations on the processing
and incorporation of the F protein in BVs was determined by
Western analysis (Fig. 5). An antibody against the major nu-
cleocapsid protein (anti-VP39) served as an internal control to
determine the amount of BVs used in the analysis. Results
indicated that all mutant F proteins were present in BVs. The
amounts of BVs for each recombinant virus were estimated to
be similar, except for SeFV158R (lane 9) and SeFK160L (lane
10), where less BVs were used (Fig. 5D). The AcMNPV GP64
protein could be detected with the repair virus (Fig. 5C, lane 1)
as well as for the viruses propagated in Sf9Op1D cells (Fig. 5C,
lanes 4, 6, 14, and 15). Western analysis with antibodies against
the SeMNPV F1 and F2 indicated that the incorporation of the
F protein in the BVs was reduced for SeFF152R, SeFM155R,
SeFM166R, and SeFR149K (Fig. 5A and B, lanes 6, 7, 13, and 15,
respectively) compared to that of native SeF protein (Fig. 5A
and B, lanes 1). Furthermore, all mutant F proteins, except
SeFR149K (Fig. 5A, lane 15), lacking a furin cleavage site, were
properly cleaved into F1 (Fig. 5A) and F2 (Fig. 5B) fragments.
Viral infectivity of f gene-pseudotyped gp64-null AcMNPV
viruses. To characterize the effect of the mutations on viral
infectivity of the mutant gp64-null viruses, one-step growth
experiments were performed. Sf21 cells were infected at an
MOI of 5.0 TCID50 U/cell. At different time points postinfec-
tion, the amount of infectious BVs was determined (Fig. 6A).
The virus titers for the native SeF and the SeFNdeI mutant were
not significantly different, indicating that the silent mutation to
generate the NdeI site had no effect on BV infectivity and
propagation. The one-step growth results for SeFNdeI is there-
fore left out of the graph (Fig. 6). Except for SeFV158R, the
virus titers of the other mutants did not significantly differ from
that of SeF. The virus titer of SeFV158R remained significant
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lower than that of the authentic SeF. This indicates that the
mutations had hardly any effect on the amount of BV produced
over time. A different behavior was seen when Sf21 cells were
infected at an MOI of 0.5 TCID50 U/cell (Fig. 6B), so that not
all cells were infected in the first round. In this experiment, the
effect of the mutations on viral infectivity could be determined,
since the amount of BV production over time was not altered,
except for SeFV158R. Also, this time the virus titers of SeF
NdeI
were almost identical to that of SeF (data not shown). In the
situation of 0.5 TCID50 U/cell, only the one-step growth results
for SeFL151R, SeFG164A, and SeFM166R were similar to those
for SeF. The titer of SeFG156A shows a drop between 48 and
72 h postinfection, but at 144 h postinfection, the titer was
elevated to levels similar to that of SeF. The virus titers of
SeFM155R, SeFV158R, SeFK160L, and SeFF163R showed a dra-
matic decrease compared to that of SeF. Thus, mutations in
the fusion peptide affect viral infectivity (Fig. 6B), presumably
the dynamics of viral spread, rather than viral production (Fig.
6A).
DISCUSSION
Posttranslational cleavage is a general mechanism to acti-
vate the fusion proteins of enveloped viruses (21). Recently, it
has been shown that this is also the case for the baculovirus F
protein, where two subunits are generated, F1 and F2 (24, 43).
Cleavage of envelope fusion proteins usually occurs in front of
a conserved hydrophobic region, the fusion peptide. The N
terminus of the SeMNPV membrane-anchored domain (F1)
contains striking similarities with the fusion peptides of other
viruses: (i) the domain is well conserved among its functional
homologs, (ii) it is relatively hydrophobic, (iii) it can be mod-
eled as an amphipathic helix, and (iv) it contains conserved
glycines at one side of the helix (Fig. 1 and 2). The helical
FIG. 3. Transfection-infection assays for viral propagation. Sf21 cells were transfected with indicated mutant gp64-null bacmids pseudotyped
with f genes, incubated for 5 days, and stained for GUS activity (A1 to O1). Supernatants from the transfected cells were used to infect Sf21 cells
(A2 to O2), which were incubated for 72 h and subsequently stained for GUS activity. Stained cells (infected cells) indicate that infectious virions
were generated in the transfected cells. Bacmids that failed to propagate an infection in Sf21 cells (D2, F2, N2, and O2) were propagated in cells
expressing constitutive O. pseudogata MNPV GP64 (Sf9Op1D). Sf9Op1D cells were transfected with indicated gp64-null bacmids (P1 to S1) and
incubated for 5 days; then supernatants were transferred to Sf9Op1D and stained for GUS activity after 72 h (P2 to S2). Indicated gp64-null AcMNPV
bacmids are pseudotyped with AcGP64 (AcMNPV gp64), SeF (SeMNPV f), SeFNdeI (SeMNPV f with silent mutation generating an NdeI
restriction site), F (no envelope fusion gene), SeFL151R, SeFF152R, SeFM155R, SeFG156A, SeFV158R, SeFK160L, SeFF163R, SeFG164A, SeFM166R
(SeMNPV f with mutations causing amino acid substitution in the putative fusion peptide as indicated in the subscript), SeF151-170 (SeMNPV f
with a deletion of the segment encoding amino acids 151 to 170), and SeFR149K (SeMNPV f with mutations causing an amino acid substitution in
the furin cleavage site).
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nature of the corresponding region of LdMNPV F has recently
been determined by circular dichroism (M. Pearson and G. F.
Rohrmann, Abstr. 22nd Annu. Meet. Am. Soc. Virol., abstr.
W53-5, 2003).
However, there are also some striking differences with ver-
tebrate viral fusion peptides. Fusion peptides of the latter are
rich in alanines while the first alanine (residue 22) in the
SeMNPV F1 N terminus is found outside the conserved region.
Another difference is that N-terminal fusion peptides of most
vertebrate viral fusion proteins are generally apolar, whereas
the SeMNPV F1 N terminus contains six polar amino acids
(N153, H157, D159, K160, D167, and S168). Other baculovirus F
proteins may have up to nine polar amino acids in this region
(Fig. 1). However, the fusion peptide of influenza hemagglu-
tinin also contains two to three polar residues (26). It is very
well possible that the polar amino acids force the N terminus
of F1 to insert in the membrane in a more perpendicular angle,
with the polar amino acids to the hydrophilic side of the phos-
pholipids compared to other fusion peptides.
The importance of the SeMNPV F1 N terminus for virus
infection and propagation was investigated by a series of amino
acid substitutions. AcMNPV virions, lacking gp64, were
pseudotyped with mutant f genes and assayed (results are sum-
marized in Table 2). A similar experimental system has been
FIG. 4. PCR and restriction enzyme analyses of purified BV DNA to verify the genotype of indicated pseudotyped vAcGP64	 viruses as
described in the legend to Fig. 3. (A) PCR with f gene-specific primer pairs used to examine mutant viral DNAs amplifying an 834-bp fragment,
when the virus contains the f gene, except for SeF151-170, where a 773-bp fragment was amplified. (B) Restriction enzyme analysis of PCR-
amplified DNA fragments. Mutant F genes have, in addition to the incorporated NdeI site, an additional restriction site, which is used to distinguish
the viruses (Table 1). The SeFR149K mutant has neither a NdeI site nor an additional restriction site.
FIG. 5. Western blot analysis of gp64-null BVs pseudotyped with indicated (mutant) f genes as described in the legend to Fig. 3. Infectious BVs
were generated in Sf21 cells (lanes 1 to 3, 5, 6, and 8 to 13), and BVs, which are not able to propagate in Sf21 cells, were propagated in Sf9Op1D
cells (lanes 4, 7, 14, and 15). Blots were probed with antibodies anti-F1 (A), anti-F2 (43) (B), and anti-GP64 (monoclonal antibody AcV5) (14)
(C). (D) An anti-nucleocapsid antibody (anti-VP39) was used as an internal control for each preparation of purified BVs (40).
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used to analyze the effect of mutations in the Ebola virus
glycoprotein fusion peptide through pseudotyping of the vesic-
ular stomatitis virus lacking its own fusion protein (18). The F
protein with a deletion of the N terminus (SeF151-170) was not
able to produce infectious virus (Fig. 3), in spite of its ability to
be incorporated in BVs and the occurrence of the posttrans-
lational cleavage (Fig. 5). This suggests that this domain is not
involved in virion assembly but plays an important role in
baculovirus entry into cells.
Glycines, as well as their conserved positions in the fusion
peptides, seem to be important for the function of viral fusion
proteins (7). It is supposed that glycine residues may provide
the proper balance of amphipathicity necessary for merging
virus and cell membranes or may be important for an oblique
insertion of the fusogenic peptide into the target membrane
(15). In this study, the specific role of the two conserved glycine
residues in the putative fusion peptide of SeMNPV F was
addressed by converting these into alanines. These substitu-
tions might increase the stability of the possible -helical con-
formation of the F1 N terminus. The G-to-A mutations in the
Sendai virus fusion peptide led to increased fusion activity of
the fusion protein (16) while for the Semliki Forest virus E1
protein it caused fusion at a lower pH (22). With the SeMNPV
F protein, the G-to-A mutations showed no notable effect.
However, these results are in line with results obtained for the
Ebola virus glycoprotein fusion peptide (18), where one of the
mutations of the glycines also had no effect on the virus titer
and the incorporation of the fusion protein in virions.
Arginine was substituted for conserved as well as noncon-
served hydrophobic residues in the fusion peptide of the
SeMNPV F protein. Introduction of a polar residue in the
hydrophobic face of the amphipathic helix is expected to result
in either a shorter (SeFL151R or SeFM166R), narrower
(SeFF152R, SeFM155R, or SeFF163R), or disrupted (SeFV158R)
hydrophobic face. The alterations can possibly disturb the he-
lical conformation or the insertion of the helix in the host
membrane and, hence, may have an effect on infectivity.
Leucine was substituted for the conserved polar lysine
FIG. 6. One-step growth results are shown for gp64-null AcMNPV viruses pseudotyped with wild-type SeF and SeF mutants as described in the
legend to Fig. 3. Sf21 cells were infected with an MOI of 5.0 TCID50 U/cell (A) or 0.5 TCID50 U/cell (B), and supernatants were harvested at the
indicated times postinfection and titrated on Sf9Op1D cells. Each data point represents the average of the results from two or three independent
infections. Error bars represent standard deviations.
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(SeFK160L), which decreases the hydrogen bonding potency of
the back face of the helix. Despite all the substitutions, there
was no notable effect on incorporation of F proteins in BVs
and on the processing of the mutant F proteins (Fig. 5). Only
SeFF152R was not able to produce infectious virus (Fig. 3),
suggesting a critical role of this amino acid in fusion. Similar
results with an F-to-R conversion have been obtained for the
Ebola glcyoprotein (18).
The virions pseudotyped with the SeFM155R, SeFF163R,
SeFV158R (hydrophilic substitutions), and SeFK160L (hydropho-
bic substitution) genes were all impaired in their virus propa-
gation dynamics (Fig. 6B). For SeFM155R, this could be caused
by a reduced incorporation of F protein in BVs (Fig. 5, lane 7).
In contrast, when cells were infected with a higher dose, only
the titer of virus pseudotyped with SeFV158R was significantly
lower than that of native SeF (Fig. 6A). Such a V-to-R con-
version has been shown to reduce the fusion activity of the
murine leukemia virus fusion protein (19). However, Western
analysis suggested that the amount of BVs produced is ex-
tremely low (Fig. 5, lane 9). It is very well possible that this is
due to a defect in transport of the protein to the cell mem-
brane, caused by incorrect folding of the protein.
The mutations L151R and M166R did not result in a signif-
icant drop in virus titers, although the incorporation of
SeFM166R in BVs was somewhat affected. The L
151 and M166
residues are the first and the last hydrophobic amino acids of
the putative fusion peptide, and this suggests that the F protein
can properly function with a smaller hydrophobic face. How-
ever, this does not imply that the borders of the putative fusion
peptide of SeMNPV F are well defined, because the two con-
served aspartic acid residues D167 and D170 also appeared to be
important for the fusogenic activity of the LdMNPV F protein
(33).
The N-terminal domain of the SeMNPV F1 subunit is most
likely involved in the entry and infectivity of BVs, and further
credence is given for the role of this domain as a fusion pep-
tide. Future biochemical studies involving the three-dimen-
sional structure of the fusion peptide should indicate how the
active fusion peptide is folded and how the behavior of the
site-specific mutant fusion peptides can be explained. Experi-
ments to this end are in progress.
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